| Mr Nicholas W Muller, CRNA | |
|
9100 W 74th St, Shawnee Mission, KS 66204-4004 | |
| (913) 676-2679 | |
| (913) 789-3191 |
| Full Name | Mr Nicholas W Muller |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 20 Years |
| Location | 9100 W 74th St, Shawnee Mission, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013984822 | NPI | - | NPPES |
| P00234278 | Other | KS | RR MEDICARE |
| 918794512 | Medicaid | MO | |
| 200258370B | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 14-92769-051 (Kansas) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | 55343 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kansas City Orthopaedic Institute | Leawood, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesia Associates Of Kansas City Pa | 1951206168 | 222 |
News Archive
University Hospitals Seidman Cancer Center physicians have started the world's first clinical trial using a new form of stereotactic body radiotherapy (SBRT) to deliver radiation to a specific area of the prostate invaded with cancer - instead of the entire gland. The study aims to determine if treating a targeted cancer region within the prostate in early stage prostate cancer can increase treatment options and reduce the side effects of radiation.
News outlets report on the growing need for long-term care and offer insights into the home care workforce.
The risk for abdominal obesity may be increased as much as fourfold for patients with multi-episode schizophrenia compared with the rest of the population, reveal findings from a meta-analysis.
Genentech, Inc., a wholly-owned member of the Roche Group and Biogen Idec, today announced that a Phase III study (PRIMA) showed that patients with follicular lymphoma who continued receiving Rituxan (rituximab) alone after responding to Rituxan and chemotherapy lived longer without their disease worsening (progression-free survival or PFS) than those who did not continue to receive Rituxan.
› Verified 4 days ago
| Entity Name | Midwest Anesthesia Associates, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336192392 PECOS PAC ID: 4981597838 Enrollment ID: O20040204000690 |
News Archive
University Hospitals Seidman Cancer Center physicians have started the world's first clinical trial using a new form of stereotactic body radiotherapy (SBRT) to deliver radiation to a specific area of the prostate invaded with cancer - instead of the entire gland. The study aims to determine if treating a targeted cancer region within the prostate in early stage prostate cancer can increase treatment options and reduce the side effects of radiation.
News outlets report on the growing need for long-term care and offer insights into the home care workforce.
The risk for abdominal obesity may be increased as much as fourfold for patients with multi-episode schizophrenia compared with the rest of the population, reveal findings from a meta-analysis.
Genentech, Inc., a wholly-owned member of the Roche Group and Biogen Idec, today announced that a Phase III study (PRIMA) showed that patients with follicular lymphoma who continued receiving Rituxan (rituximab) alone after responding to Rituxan and chemotherapy lived longer without their disease worsening (progression-free survival or PFS) than those who did not continue to receive Rituxan.
› Verified 4 days ago
| Entity Name | Anesthesia Associates Of Kansas City Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174504732 PECOS PAC ID: 1951206168 Enrollment ID: O20050721001069 |
News Archive
University Hospitals Seidman Cancer Center physicians have started the world's first clinical trial using a new form of stereotactic body radiotherapy (SBRT) to deliver radiation to a specific area of the prostate invaded with cancer - instead of the entire gland. The study aims to determine if treating a targeted cancer region within the prostate in early stage prostate cancer can increase treatment options and reduce the side effects of radiation.
News outlets report on the growing need for long-term care and offer insights into the home care workforce.
The risk for abdominal obesity may be increased as much as fourfold for patients with multi-episode schizophrenia compared with the rest of the population, reveal findings from a meta-analysis.
Genentech, Inc., a wholly-owned member of the Roche Group and Biogen Idec, today announced that a Phase III study (PRIMA) showed that patients with follicular lymphoma who continued receiving Rituxan (rituximab) alone after responding to Rituxan and chemotherapy lived longer without their disease worsening (progression-free survival or PFS) than those who did not continue to receive Rituxan.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Nicholas W Muller, CRNA 9100 W 74th St, Shawnee Mission, KS 66204-4004 Ph: (913) 676-2679 | Mr Nicholas W Muller, CRNA 9100 W 74th St, Shawnee Mission, KS 66204-4004 Ph: (913) 676-2679 |
News Archive
University Hospitals Seidman Cancer Center physicians have started the world's first clinical trial using a new form of stereotactic body radiotherapy (SBRT) to deliver radiation to a specific area of the prostate invaded with cancer - instead of the entire gland. The study aims to determine if treating a targeted cancer region within the prostate in early stage prostate cancer can increase treatment options and reduce the side effects of radiation.
News outlets report on the growing need for long-term care and offer insights into the home care workforce.
The risk for abdominal obesity may be increased as much as fourfold for patients with multi-episode schizophrenia compared with the rest of the population, reveal findings from a meta-analysis.
Genentech, Inc., a wholly-owned member of the Roche Group and Biogen Idec, today announced that a Phase III study (PRIMA) showed that patients with follicular lymphoma who continued receiving Rituxan (rituximab) alone after responding to Rituxan and chemotherapy lived longer without their disease worsening (progression-free survival or PFS) than those who did not continue to receive Rituxan.
› Verified 4 days ago
Robb A. Aerni, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Shawnee Mission, KS 66204 Phone: 913-676-2679 Fax: 913-789-3191 | |
Lisa A Noyes, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Shawnee Mission, KS 66204 Phone: 913-632-2230 Fax: 913-632-2297 | |
Marlene F. Bailey, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Shawnee Mission, KS 66204 Phone: 913-632-2230 Fax: 913-632-2297 | |
Erin M. Steinbrink, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Shawnee Mission, KS 66204 Phone: 913-632-2230 Fax: 913-632-2297 | |
Sarah-grace Miller Hamm, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Shawnee Mission, KS 66204 Phone: 913-632-2230 Fax: 913-632-2297 | |
Stephanie A. Klamm, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Shawnee Mission, KS 66204 Phone: 913-676-2679 Fax: 913-789-3191 | |
Danelle Lynn Diorio, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 9100 W 74th St, Shawnee Mission, KS 66204 Phone: 913-632-2230 Fax: 913-632-2297 |